Looks to me they are trying to commercialize a very similar (in concept) immunotherapy vaccine platform, so similar that one wonders about whether they are infringing or intend on licensing the nwbo patents.
However I remember something about the DCs/vaccine themselves not being patentable but rather the production process and key features being what the patents sre on, as well as a broad combination of dcvax set of patents.
Are you suggesting a direct connection between the companies and/or their products, as in dcvax being used or the IP licensed?
Market Data 
Markets 
AI
